Seffiller — autologous regenerative treatment
- Best for: Selected patients with significant volume loss; autologous preference
- Downtime: 5–10 days of swelling
- Lasts: Variable — a proportion of transferred fat integrates and lasts; results vary
For patients suited to it, Seffiller is the clinic’s autologous regenerative treatment using the patient’s own fat via the SEFFI / microfat technique. Seffiller is autologous — it uses the patient’s own tissue, not a manufactured product — and is used for facial and skin volume restoration. A proportion of the transferred fat integrates and provides long-lasting volume, while the rest is reabsorbed by the body; results vary between individuals.
Seffiller is not described as permanent because retention is partial and variable. It is not a polynucleotide and not an off-the-shelf HA filler. Suitability is decided carefully at consultation; not every patient is a candidate, and Seffiller is one option within a wider plan rather than the only option.









